Patents
Patents for C07K 16 - Immunoglobulins, e.g. monoclonal or polyclonal antibodies (149,320)
10/1995
10/10/1995US5457132 Kit used in the treatment for hypertension using combination therapy involving exogenous calcium and calcium channel blockers
10/10/1995US5457038 Natural killer stimulatory factor
10/10/1995CA1337264C Enzyme immunoassay for detecting hiv antigens in human sera
10/05/1995WO1995026506A1 Methods for detecting calpain activation and indentifying calpain inhibitors
10/05/1995WO1995026403A1 Antibodies against e-selectin
10/05/1995WO1995026365A1 Synthetic peptide based immunogens for the treatment of allergy
10/05/1995WO1995026364A1 Monoclonal antibodies recognizing tie-receptor and their use
10/05/1995WO1995026363A1 Neurotrophin-6: a new member of the neurotrophin family
10/05/1995WO1995026362A1 Peptides for diagnostics and therapeutics
10/05/1995WO1995026203A1 Wound healing
10/05/1995WO1995026196A1 CHIMERIC INFECTIOUS BURSAL DISEASE VIRUS cDNA CLONES, EXPRESSION PRODUCTS AND VACCINES BASED THEREON
10/05/1995WO1995023859A3 Novel forms of t cells costimulatory molecules and uses therefor
10/05/1995WO1995017425A3 Markers of organ rejection
10/05/1995CA2186856A1 Chimeric infectious bursal disease virus cdna clones, expression products and vaccines based thereon
10/05/1995CA2186595A1 Synthetic peptide based immunogens for the treatment of allergy
10/05/1995CA2186455A1 Antibodies against e-selectin
10/05/1995CA2185141A1 Methods for detecting calpain activation and indentifying calpain inhibitors
10/04/1995EP0675203A1 Integrationvectors for producing genes, which produce recombinant antibodies
10/04/1995EP0675201A1 Compositions and methods for stimulating megakaryocyte growth and differentiation
10/04/1995EP0675200A1 A FAS ligand, a fragment thereof and DNA encoding the same
10/04/1995EP0675199A2 A DNA which codes for the variable region of the anti-human influenza A type virus antibody recognizing the H,N, and H2N2 subtypes of haemagglutinin
10/04/1995EP0675136A2 Antibodies to mammalian interleukin-4 and peptides useful as antigens in their production
10/04/1995EP0674734A1 Runway-maintenance device.
10/04/1995EP0674710A1 Peptides and anti-sense peptides with broad neoplastic specificity
10/04/1995EP0674661A1 Assay and treatment for demyelinating diseases such as multiple sclerosis
10/04/1995EP0674659A1 Peptides and vaccines derived from nematode tubulin
10/04/1995EP0674656A1 Recombinant mammalian calcitonin receptors and uses thereof
10/04/1995EP0547059B1 Pancreas-elastasis-1-specific antibody, a process for obtaining it and a test kit containing such antibodies
10/04/1995EP0529019B1 Nematode vaccine
10/04/1995CN1109505A Interferon-alpha/beta binding protein, its preparation and use
10/04/1995CN1109469A Macrocyclic bifunctional chelants, complexes threof and their antibody conjugates
10/03/1995US5455337 Treatment of asthma, helminth infections
10/03/1995US5455331 Enriched whey protein fractions and method for the production thereof
10/03/1995US5455330 Isolated pure protein having specified amino acid sequence
10/03/1995US5455179 Quantitative analysis using polypeptide
10/03/1995US5455031 Polypeptide with 46 Kdalton HMFG differentiation antigen binding specificity, composition, kit and diagnostic method
10/03/1995US5455030 Immunotheraphy using single chain polypeptide binding molecules
09/1995
09/28/1995WO1995025813A1 Germline mutations in the mts gene and method for detecting predisposition to cancer at the mts gene
09/28/1995WO1995025809A1 Compacted nucleic acids and their delivery to cells
09/28/1995WO1995025795A1 HUMAN trk RECEPTORS AND NEUROTROPHIC FACTOR INHIBITORS
09/28/1995WO1995025794A1 Anti-igf-i monoclonal antibody
09/28/1995WO1995025740A1 Isolated peptides derived from mage tumor rejection antigen precursors which complex with hla-a2 molecules
09/28/1995WO1995025739A1 Isolated, mage-3 derived peptides which complex with hla-a2 molecules and uses thereof
09/28/1995WO1995025543A1 Methods and compositions useful for inhibition of angiogenesis
09/28/1995WO1995025540A1 Method for reducing immune and hemostatic dysfunctions during extracorporeal circulation
09/28/1995WO1995025530A1 Isolated tumor rejection antigen precursor mage-2 derived peptides, and uses thereof
09/28/1995WO1995025528A1 Method of enhancing the immunotherapeutic activity of immune cells by depletion/positive selection
09/28/1995WO1994025597A3 METHODS AND COMPOSITIONS FOR DETECTION OF $i(SALMONELLA)
09/28/1995CA2186108A1 Method for reducing immune and hemostatic dysfunctions during extracorporeal circulation
09/28/1995CA2186016A1 Method of enhancing the immunotherapeutic activity of immune cells by depletion/positive selection
09/28/1995CA2186006A1 Isolated tumor rejection antigen precursor mage-2 derived peptides, and uses thereof
09/28/1995CA2186005A1 Isolated, mage-3 derived peptides which complex with hla-a2 molecules and uses thereof
09/27/1995EP0674178A2 Cyclosporin immunoassay
09/27/1995EP0674176A1 Electrochemiluminescent rhenium moieties and methods of production
09/27/1995EP0674175A2 Chemical modification of antibodies and antigens
09/27/1995EP0674003A2 Modulatory proteins of human CNS receptors
09/27/1995EP0673948A1 Pepticles derived from a retrovirus of the HIV-group and their use
09/27/1995EP0673440A1 Mammalian muscle nad:arginine adp-ribosyltransferase
09/27/1995EP0673426A1 Platelet-activating factor acetylhydrolase
09/27/1995EP0673425A1 Dna encoding chitin deacetylase
09/27/1995EP0673418A1 Monoclonal antibodies directed against the microtubule-associated protein tau, hybridomas secreting these antibodies, antigen recognition by these monoclonal antibodies and their applications
09/27/1995EP0673417A1 LIGAND BINDING VARIABLE DOMAIN (V-MIN) COMPRISING A FRAMEWORK REGION WITH A CYCLICALLY PERMUTED CENTRAL $g(b)-BARREL
09/27/1995EP0673391A1 Activation-dependent protein expressed on the surface of activated platelets and antibodies thereto
09/27/1995EP0673390A1 Delta-like gene expressed in neuroendocrine tumors
09/27/1995EP0673389A1 Antibodies for gm-csf receptor and uses thereof
09/27/1995EP0673255A1 Monoclonal antibody which specifically binds to tumor vascular endothelium and uses thereof
09/27/1995EP0593460B1 Method and apparatus for biopolymer synthesis
09/27/1995EP0348490B1 Treatment of type 2 diabetes mellitus
09/27/1995EP0261225B1 Lectin complex and method and probe for making same
09/27/1995CN1109260A A retroviral vector capable of transducing the aldehyde dehydrogenase-1 gene and uses of said vector
09/26/1995US5453371 Bacterial collagenase gene of Vibrio alginolyticus
09/26/1995US5453362 Herpes virus, viricides
09/26/1995US5453361 Method for producing biologically active human brain derived neurotrophic factor
09/26/1995US5453359 Immunoassay and kit for in vitro detection of soluble DesAABB fibrin polymers
09/26/1995US5453354 Method for improving sperm motility
09/26/1995US5453269 Heterobifunctional antibodies having dual specificity for fibrin and thrombolylic agents and methods of use
09/26/1995CA2145623A1 Modulatory proteins of human cns receptors
09/22/1995CA2144936A1 Antibody conjugates with improved properties
09/21/1995WO1995025173A1 Methods for identifying inhibitors of integrin activation
09/21/1995WO1995025172A1 Recombinant antibody fragments which are synthesized and biotinylated in e. coli, their use in immunoassays and immunopurification techniques
09/21/1995WO1995025167A1 Anti-egfr single-chain fvs and anti-egfr antibodies
09/21/1995WO1995025126A1 Antibodies to interleukin-8 receptors and methods of use
09/21/1995WO1995025125A1 Dna encoding cai resistance proteins and uses thereof
09/21/1995WO1995025117A1 Polypeptides of lipopolysaccharide binding protein
09/21/1995WO1995025113A1 Synthetic compounds which bind to h. pylori, and uses thereof
09/21/1995WO1995024927A1 Immunotherapeutic method of treating cancerous diseases by administration of gamma globulins
09/21/1995WO1995024922A1 Chlamydia vaccines and process
09/21/1995WO1995024921A1 A medical use of matrix metalloproteinase inhibitors for inhibiting tissue contraction
09/21/1995WO1995024918A1 Use of il-12 and il-12 antagonists in the treatment of autoimmune diseases
09/21/1995WO1995024917A1 Skin treatment composition
09/21/1995WO1995024916A1 Retropeptides, antibodies thereto, and uses thereof for vaccination and in vitro diagnosis
09/21/1995WO1995024913A1 Treatment of graft-versus-host disease
09/21/1995WO1995024904A1 Synergistic inhibition of hiv-1 infection using a nucleoside reverse transcriptase inhibitor and anti-hiv-1 antibodies
09/21/1995WO1995018826A3 Purified primate ctla-8 antigens and related reagents
09/21/1995DE4406813A1 Filter layer with monoclonal antibody for allergen removal
09/21/1995CA2185446A1 Methods for identifying inhibitors of integrin activation
09/21/1995CA2185341A1 Dna encoding cai resistance proteins and uses thereof
09/21/1995CA2184269A1 Immunotherapeutic method of treating cancerous diseases by administration of gamma globulins
09/21/1995CA2181162A1 Skin treatment composition
09/20/1995EP0672756A1 Monoclonal antibody recognizing fk506-binding protein, method of assaying fk506-binding protein level, and kit thereof